Thrombogenics entered the industry of Research and Development Laboratories in 0 and has grown to employ 1 to 4 people, generating an annual revenue of Unknown. The NAICS classifies this business under the code 5417110, which describes it as a Research and Development Laboratories. For further clarification, the SIC classifies this business under the code 8731 and described it as a Research and Development Laboratories. The business provides service to the B2B market.
To acquire more information, please contact Stephen Pakola, Vice President by calling (212) 201-0920 during business hours. You can also write to the business’ Single Location at 1560 Broadway, New York City, New York NY 10036. You can also visit the company’s website at thrombogenics.com. View this business’ social media profiles on Twitter or on Facebbok .
Company: | Thrombogenics |
Representative: | Stephen Pakola, Vice President |
Place of Business: | 1560 Broadway, New York City, NY 10036 |
Contact Number: | (212) 201-0920 |
Website: | thrombogenics.com |
Type of Service: | Research and Development Laboratories |
SIC Number: | 8731 |
NAICS Number: | 5417110 |
Locality: | Single Location |
Market Type: | B2B (Business to Business) |
Income/Year: | Unknown |
Laborers: | 1 to 4 |
Share This Company: |
Thrombogenics is a company operating from New York, New York providing professional Research and Development Laboratories and relevant B2B variables. It was founded in 0 and registered with the SIC code 8731 as Research and Development Laboratories, and with the NAICS code 5417110 as Research and Development Laboratories.
With a current employee count of 1 to 4, Thrombogenics has gone to report making Unknown per annum on its journey towards growth. This company invites you to contact its representative Stephen Pakola, Vice President at (212) 201-0920 for related queries, or to locate its Single Location using the coordinates 40.759396,-73.992846.
The Single Location can also be found at the street address 1560 Broadway in New York City, New York 10036 and can be engaged online through the company website at thrombogenics.com, the company Twitter , and Facebook page .